GlaxoSmithKline | GSK - Market Capitalization

Stock Price
2,167.50
Daily Change
-46.50 -2.10%
Monthly
16.38%
Yearly
48.36%
Q1 Forecast
2,168.74

GlaxoSmithKline reported GBP89.76B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 391.49B 12.34B Feb/2026
Alcon AG USD 29.11B 5.61B Sep/2025
Almirall EUR 2.75B 8.36M Feb/2026
Amgen USD 201.45B 25.2B Feb/2026
argenx SE USD 39.05B 12.79B Feb/2026
AstraZeneca USD 222.33B 65.82B Feb/2026
Bayer EUR 27.23B 2.14B Sep/2025
Biogen USD 27.01B 1.19B Feb/2026
Bristol-Myers Squibb USD 123.58B 13.77B Feb/2026
Eli Lilly USD 1.01T 3.37B Feb/2026
Fresenius EUR 28.71B 1.12B Feb/2026
Fresenius Medical Care EUR 11.19B 770.21M Feb/2026
Galapagos EUR 1.93B 10.54M Feb/2026
Genmab DKK 80.88B 7.82B Jun/2025
Gilead Sciences USD 183.59B 31.31B Feb/2026
GlaxoSmithKline GBP 87.33B 12.98B Feb/2026
Glaxosmithkline GBP 106.96B 20.08B Feb/2026
GRIFOLS EUR 4.62B 2.88B Feb/2026
Hikma Pharmaceutical USD 6.06B 1.64B Jun/2025
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 47.59B 239.13M Sep/2025
Merck USD 300.37B 39.11B Feb/2026
Novartis USD 265.66B 9.48B Sep/2025
Novo Nordisk A/S DKK 1.54T 86.62B Feb/2026
Orion EUR 7.27B 1.67B Feb/2026
Pfizer USD 152.89B 11.32B Feb/2026
Philips EUR 24.21B 1.83B Feb/2026
Recordati EUR 9.81B 343.76M Feb/2026
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Smith & Nephew USD 3.93B 9.39B Jan/2026
UCB EUR 32.47B 4.91B Jun/2025